15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγand Reduction in NF-κB Activity

Kan Chen,Jingjing Li,Junshan Wang,Yujing Xia,Weiqi Dai,Fan Wang,Song Miao,Ping Cheng,Yan Zhang,Chengfen Wang,Jing Yang,Rong Zhu,Huawei Zhang,Yuanyuan Zheng,Jie Lü,Zhuoyi Fan,Yingqun Zhou,Chuanyong Guo
DOI: https://doi.org/10.1155/2014/215631
2014-01-01
PPAR Research
Abstract:Objective . 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) reduces inflammation and has been identified as an anti-inflammatory prostaglandin in numerous animal models. In this study, we investigated both effects of 15d-PGJ2 and its protection mechanism in concanavalin A- (ConA-) induced autoimmune hepatitis in mice. Materials and Methods . In vivo, Balb/C mice were injected with ConA (25 mg/kg) to induce acute autoimmune hepatitis, and 15d-PGJ2 (10 μ g or 25 μ g) was administered 1 h before the ConA injection. The histological grade, proinflammatory cytokine levels, and NF- κ B and PPAR γ activity were determined 6, 12, and 24 h after the ConA injection. In vitro, LO2 cells and RAW264.7 cells were pretreated with 15d-PGJ2 (2 μ M) 1 h before the stimulation with ConA (30 μ g/mL). The NF- κ B and PPAR γ activity were determined 30 min after the ConA administration. Results . Pretreatment with 15d-PGJ2 reduced the pathological effects of ConA-induced autoimmune hepatitis and significantly reduced the levels of cytokines after injection. 15d-PGJ2 activated PPAR γ , blocked the degradation of I κ B α , and inhibited the translocation of NF- κ B into the nucleus. Conclusion . These results indicate that 15d-PGJ2 protects against ConA-induced autoimmune hepatitis by reducing proinflammatory cytokines. This reduction in inflammation may correlate with the activation of PPAR γ and the reduction in NF- κ B activity.
What problem does this paper attempt to address?